Posted in Collaborations, Nephrology
Faran S.A. and Sandoz, a member of the Novartis Group, after their successful cooperation, are pleased to announce the expansion of their cooperation, undertaking the promotion and distribution of another product with the active ingredient Epoetin Alfa.
This collaboration will strengthen the leading position of Faran S.A. in the field of Biotechnology, as Sandoz is a world leader in the research, development and production of Biosimilars.